Current and Future Treatment Directions in T2DM

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1607, 2007-01, pp. : 9-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

T2DM treatment ADVANCE comes with caveats

Inpharma, Vol. 1, Iss. 1643, 2008-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

Multisystem Langerhans Cell Histiocytosis in Children: Current Treatment and Future Directions

By Minkov Milen

Pediatric Drugs, Vol. 13, Iss. 2, 2011-04 ,pp. : 75-86

Adis International

Access to resources Recommend Favorite

Hypopigmentary Skin Disorders: Current Treatment Options and Future Directions

By Hartmann A. Bröcker E-B. Becker J.C.

Drugs, Vol. 64, Iss. 1, 2004-01 ,pp. : 89-107

Adis International

Access to resources Recommend Favorite

Tivozanib: current status and future directions in the treatment of solid tumors

By Pal Sumanta K Bergerot Paulo G Figlin Robert A

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 12, 2012-12 ,pp. : 1851-1859

Informa Healthcare

Access to resources Recommend Favorite

T2DM treatment targets scrutinised at ADA: nothing needs to change

Inpharma, Vol. 1, Iss. 1643, 2008-01 ,pp. : 6-7

Adis International

Access to resources Recommend Favorite